Project Grant HT94252510275

Award Date 7/1/25
Completion Date 6/30/29
Dollars Obligated $2.7M
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
This federal Project Grant award, valued at $569,851.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to evaluate the effectiveness of a traumatic brain injury whole blood test on improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The award was made to the University of Pittsburgh, a major public research university, and is intended to...
This $1,526,245 Project Grant awarded on July 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund the "MITOCHONDRIAL INFLAMMATION SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project at the University of Pittsburgh. The project aims to investigate mechanisms and treatments for mild, repetitive traumatic brain injury through research on mitochondrial...
The University of Pittsburgh was awarded a $1,306,281 Project Grant under the Department of the Army's Military Medical Research and Development program (CFDA 12.420) to conduct the "MITOCHONDRIAL INFLAMMATORY SYNAPTIC SYSTEMS IMAGING OF NEUROINJURY (MISSION) FOR MILD REPETITIVE TRAUMATIC BRAIN INJURY" research project. The award began on July 1, 2024 and is scheduled for completion on June 30, 2028. The project aims to study the mechanisms of mitochondrial inflammation and synaptic...
The University of Pittsburgh received a $6,699,872 Project Grant award on September 30, 2024 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "MICROGLIAL BREAKTHROUGHS IN LONGEVITY, AGING, AND SENESCENCE AFTER TBI (MICROBLAST)", will fund advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research will explore...
This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development Program (CFDA 12.420) provides $2,495,419.00 to The Trustees of the University of Pennsylvania (Penn) to develop a blood-based biomarker for detecting blood-brain barrier dysfunction in traumatic brain injury. The project aims to transform healthcare for service members and the public by developing innovative medical solutions for the battlefield through July 1, 2023 to June 30, 2027....
The Project Grant award, titled "PROGRAM TO CHARACTERIZE EVOLVING ENDOPHENOTYPES OF DEGENERATION AFTER TRAUMATIC BRAIN INJURY (PROCEED-TBI)", was provided by the Defense Health Agency for $7,956,997.00 with a period of performance from September 30, 2023 to September 29, 2027. The grant supports biomedical research related to the Military Medical Research and Development program (CFDA 12.420), with a focus on characterizing clinically relevant animal models of traumatic brain injury...
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
This $1,416,573 federal Project Grant award was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to transform healthcare for military service members and the broader public, with a focus on advancing biomedical research across multiple disciplines. The primary awardee, Vanderbilt University Medical Center, will conduct research to develop machine learning algorithms that can diagnose mild traumatic brain...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $683,442 Project Grant on September 1, 2023 to The Trustees of the University of Pennsylvania to conduct a 3-year study on "Trajectories of Neuroimaging and Blood-Based Biomarkers After Remote Traumatic Brain Injury and Associations with Dementia Risk." The University of Pennsylvania will collaborate with Mayo Clinic on a sub-award to investigate longitudinal changes in brain...

This $2,699,157 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research to evaluate the effectiveness of a traumatic brain injury (TBI) whole blood test in improving assessment and triage for patients with mild TBI presenting to civilian emergency departments. The University of Pittsburgh, a major public research university, is the prime recipient of this grant with a performance period from July 1, 2025 to June 30, 2029. The research aims to explore innovative approaches to enhance the diagnosis and management of mild TBI, a prevalent condition affecting military personnel and the general public. The grant funding will enable the university to conduct sophisticated medical research and analysis to assess the clinical utility of the TBI whole blood test, with the goal of advancing evidence-based practices in emergency care and improving outcomes for patients with mild TBI.

Generated 5/13/25, 1:44 AM